Literature DB >> 3039912

Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers.

G P Rabalais, M J Levin, F E Berkowitz.   

Abstract

An enzyme-linked immunosorbent assay was performed directly on fixed, virus-infected cell monolayers to rapidly determine the susceptibility of herpes simplex virus to antiviral drugs. Susceptibility determinations by this method correlated well with those obtained by plaque reduction assay and avoided some of the drawbacks of other methods currently available.

Mesh：

Substances：

Year:  1987        PMID： 3039912      PMCID： PMC284218          DOI： 10.1128/AAC.31.6.946

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus.

Authors:  F E Berkowitz; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

2.  The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness?

Authors:  J C Drach; C Shipman
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

3.  A rapid antiviral drug test by enzyme-linked immunoassay.

Authors:  M P Landini; B Baldassarri
Journal:  Diagn Immunol       Date:  1983

4.  A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs.

Authors:  M Langlois; J P Allard; F Nugier; M Aymard
Journal:  J Biol Stand       Date:  1986-07

5.  Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis.

Authors:  H Gadler; A Larsson; E Sølver
Journal:  Antiviral Res       Date:  1984-04       Impact factor: 5.970

6.  Uptake of [125I]iododeoxycytidine by cells infected with herpes simplex virus: a rapid screening test for resistance to acyclovir.

Authors:  R B Van Dyke; J D Connor
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

7.  A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds.

Authors:  B Wahren; J Harmenberg; V A Sundqvist; B Levén; B Sköldenberg
Journal:  J Virol Methods       Date:  1983-03       Impact factor: 2.014

8.  Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine.

Authors:  J Harmenberg; B Wahren; B Oberg
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

9.  Rapid assay of herpes simplex virus sensitivity to drugs.

Authors:  J E Thornton; K O Smith
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-04
  9 in total
  9 in total

1.  In situ enzyme-linked immunosorbent assay to quantitate in vitro development of Eimeria tenella.

Authors:  J A Olson
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 2.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus.

Authors:  E M Swierkosz; D R Scholl; J L Brown; J D Jollick; C A Gleaves
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

4.  Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.

Authors:  Jeffry J Leary; Robert Wittrock; Robert T Sarisky; Adriana Weinberg; Myron J Levin
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

5.  Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet.

Authors:  I Pavić; A Hartmann; A Zimmermann; D Michel; W Hampl; I Schleyer; T Mertens
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

6.  In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2.

Authors:  A Weinberg; B J Bate; H B Masters; S A Schneider; J C Clark; C G Wren; J A Allaman; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

7.  Application of real-time PCR for determination of antiviral drug susceptibility of herpes simplex virus.

Authors:  Růzena Stránská; Anton M van Loon; Merjo Polman; Rob Schuurman
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

8.  Activity of penciclovir against Epstein-Barr virus.

Authors:  T H Bacon; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

9.  An ELISA system for evaluating antiretroviral activity against Rauscher murine leukemia virus.

Authors:  M G Hollingshead; L Westbrook; M J Ross; J Bailey; K J Qualls; L B Allen
Journal:  Antiviral Res       Date:  1992-06       Impact factor: 5.970
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.